Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder. The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. It is currently operating in Stealth mode. Andrew Kruegel established the biotech company in 2017 in Dobbs Ferry, New York.

List your booth number for exhibitions, ask us